HUT42329A - Process for producing compositions for curing wounds - Google Patents
Process for producing compositions for curing woundsInfo
- Publication number
- HUT42329A HUT42329A HU86420A HU42086A HUT42329A HU T42329 A HUT42329 A HU T42329A HU 86420 A HU86420 A HU 86420A HU 42086 A HU42086 A HU 42086A HU T42329 A HUT42329 A HU T42329A
- Authority
- HU
- Hungary
- Prior art keywords
- wounds
- cells
- producing compositions
- substance
- curing wounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0033—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/49—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Eye Examination Apparatus (AREA)
- Medicines Containing Plant Substances (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67647184A | 1984-11-29 | 1984-11-29 | |
US78620685A | 1985-10-10 | 1985-10-10 | |
PCT/US1985/002205 WO1986003122A1 (en) | 1984-11-29 | 1985-11-08 | Wound healing agents |
Publications (1)
Publication Number | Publication Date |
---|---|
HUT42329A true HUT42329A (en) | 1987-07-28 |
Family
ID=27101561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU86420A HUT42329A (en) | 1984-11-29 | 1985-11-08 | Process for producing compositions for curing wounds |
Country Status (16)
Country | Link |
---|---|
EP (2) | EP0383363A3 (hu) |
AT (1) | ATE78167T1 (hu) |
AU (1) | AU596954B2 (hu) |
CA (1) | CA1261259A (hu) |
CH (1) | CH673774A5 (hu) |
DE (2) | DE3590594T1 (hu) |
DK (1) | DK165169C (hu) |
FI (1) | FI85219C (hu) |
GB (1) | GB2248777B (hu) |
HU (1) | HUT42329A (hu) |
IE (1) | IE57894B1 (hu) |
IL (1) | IL77096A (hu) |
NL (1) | NL8520384A (hu) |
NO (1) | NO170194C (hu) |
SE (1) | SE8603228L (hu) |
WO (1) | WO1986003122A1 (hu) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0487116B1 (en) * | 1984-10-12 | 1999-12-29 | ZymoGenetics, Inc. | Biologically active PDGF analogs in eucaryotic cells |
US5498600A (en) * | 1984-10-12 | 1996-03-12 | Zymogenetics, Inc. | Biologically active mosaic proteins |
US5187263A (en) * | 1984-10-12 | 1993-02-16 | Zymogenetics, Inc. | Expression of biologically active PDGE analogs in eucaryotic cells |
US5045633A (en) * | 1985-02-25 | 1991-09-03 | Zymogenetics, Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
IL84911A (en) * | 1987-12-22 | 1993-04-04 | Yissum Res Dev Co | Processes for the preparation of collagen products, and pharmaceutical compositions containing the same |
US5814602A (en) * | 1988-03-17 | 1998-09-29 | Novo Nordisk A/S | Heparin-binding proteins |
US4900541A (en) * | 1988-05-06 | 1990-02-13 | Govier William C | Sunscreen composition |
IT1217938B (it) * | 1988-06-28 | 1990-03-30 | Girolamo Sirchia | Procedimento per la preparazione e la conservazione di concentrati eritrocitari e piastrinici |
US5599558A (en) * | 1989-09-15 | 1997-02-04 | Curative Technologies, Inc. | Selecting amounts of platelet releasate for efficacious treatment of tissue |
IL95641A0 (en) * | 1989-09-15 | 1991-06-30 | Curative Tech Inc | Preparation of a platelet releasate product |
US6054122A (en) * | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US7208179B1 (en) | 1990-11-27 | 2007-04-24 | The American National Red Cross | Methods for treating disease and forming a supplemented fibrin matrix |
CA2097063C (en) * | 1990-11-27 | 2006-08-08 | Howard P. Greisler | Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
US6197325B1 (en) * | 1990-11-27 | 2001-03-06 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US6559119B1 (en) | 1990-11-27 | 2003-05-06 | Loyola University Of Chicago | Method of preparing a tissue sealant-treated biomedical material |
US6117425A (en) * | 1990-11-27 | 2000-09-12 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, method of their production and use |
US5171579A (en) * | 1991-10-11 | 1992-12-15 | Genetics Institute, Inc. | Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
IL105529A0 (en) * | 1992-05-01 | 1993-08-18 | Amgen Inc | Collagen-containing sponges as drug delivery for proteins |
FR2691911B1 (fr) * | 1992-06-05 | 1994-11-25 | Delmas Olivier | Dispositif permettant l'obtention d'un surnageant de thrombocytes activés, procédé mettant en Óoeuvre le dispositif et surnageant obtenu. |
FR2696095B1 (fr) * | 1992-09-30 | 1994-11-25 | Inoteb | Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application. |
EP0637450A3 (en) * | 1993-08-04 | 1995-04-05 | Collagen Corp | Method and composition for resuscitation of hereditary tissue. |
WO1995015763A1 (en) * | 1993-12-08 | 1995-06-15 | Universite De Montreal | Process for the preparation of serum and platelet growth factors extract |
US5733545A (en) * | 1995-03-03 | 1998-03-31 | Quantic Biomedical Partners | Platelet glue wound sealant |
CZ365097A3 (cs) * | 1995-05-24 | 1998-02-18 | Cellfactors Plc. | Činidla pro diferenciaci buněk |
AU712934B2 (en) | 1995-06-06 | 1999-11-18 | Interpore International Inc. | Device and method for concentrating plasma |
US5834418A (en) * | 1996-03-20 | 1998-11-10 | Theratechnologies, Inc. | Process for the preparation of platelet growth factors extract |
US6051008A (en) | 1996-12-02 | 2000-04-18 | Angiotrax, Inc. | Apparatus having stabilization members for percutaneously performing surgery and methods of use |
US6102926A (en) | 1996-12-02 | 2000-08-15 | Angiotrax, Inc. | Apparatus for percutaneously performing myocardial revascularization having means for sensing tissue parameters and methods of use |
US6120520A (en) | 1997-05-27 | 2000-09-19 | Angiotrax, Inc. | Apparatus and methods for stimulating revascularization and/or tissue growth |
US6117444A (en) * | 1997-04-10 | 2000-09-12 | Brigham & Women's Hospital | Polyethylene glycol/microfibrillar collagen composite serves as a resorbable hemostatic agent |
AT407484B (de) | 1997-11-12 | 2001-03-26 | Bio Prod & Bio Eng Ag | Arzneimittel zur förderung der wundheilung |
US6762336B1 (en) | 1998-01-19 | 2004-07-13 | The American National Red Cross | Hemostatic sandwich bandage |
EP1091735B1 (en) * | 1998-06-22 | 2007-11-14 | Autologous Wound Therapy, Inc. | Improved enriched platelet wound healant |
US6524568B2 (en) | 1998-06-22 | 2003-02-25 | Cytomedix, Inc. | Enriched platelet wound healant |
US6432119B1 (en) | 1999-03-17 | 2002-08-13 | Angiotrax, Inc. | Apparatus and methods for performing percutaneous myocardial revascularization and stimulating angiogenesis using autologous materials |
US8293530B2 (en) | 2006-10-17 | 2012-10-23 | Carnegie Mellon University | Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
US8529956B2 (en) | 2002-03-18 | 2013-09-10 | Carnell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
EP1507543A4 (en) * | 2002-05-09 | 2006-07-26 | Cambridgemed Inc | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF WOOD WITH BLOOD PLASMA OR SERUM |
WO2004024195A1 (en) | 2002-09-10 | 2004-03-25 | American National Red Cross | Hemostatic dressing |
WO2005105121A1 (en) * | 2004-05-05 | 2005-11-10 | Synthes Gmbh | Use of platelets or platelet rich plasma (prp) |
US8529959B2 (en) | 2006-10-17 | 2013-09-10 | Carmell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
WO2009020612A1 (en) | 2007-08-06 | 2009-02-12 | Stb Lifesaving Technologies, Inc. | Methods and dressing for sealing internal injuries |
US20200224164A1 (en) | 2018-11-30 | 2020-07-16 | Cellphire, Inc. | Platelets as delivery agents |
EP3886879A4 (en) | 2018-11-30 | 2022-12-07 | Cellphire Inc. | PLATES AS DELIVERY AGENTS |
CN114072159A (zh) | 2019-05-03 | 2022-02-18 | 塞尔菲乐有限公司 | 用于生产血液产品的材料和方法 |
AU2020334903B2 (en) | 2019-08-16 | 2023-12-21 | Cellphire, Inc. | Thrombosomes as an antiplatelet agent reversal agent |
CA3170196A1 (en) | 2020-02-04 | 2021-08-12 | Cellphire, Inc. | Anti-fibrinolytic loaded platelets |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1195061A (en) * | 1966-05-27 | 1970-06-17 | Fmc Corp | Coated Structures and Methods of Forming Them. |
FR2533438B2 (fr) * | 1979-12-27 | 1986-03-07 | Sederma Sarl | Utilisation en cosmetologie des facteurs de croissance et d'extraits biologiques contenant ceux-ci |
FR2472385A1 (fr) * | 1979-12-27 | 1981-07-03 | Sederma Sa | Nouveaux extraits biologiques utilisables en cosmetologie, et procedes d'obtention de ces extraits |
DE3110560A1 (de) * | 1981-03-18 | 1982-10-14 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben" |
US4479896A (en) * | 1981-12-11 | 1984-10-30 | Antoniades Harry N | Method for extraction localization and direct recovery of platelet derived growth factor |
US4444760A (en) * | 1983-06-17 | 1984-04-24 | Merck & Co., Inc. | Purification and characterization of a protein fibroblast growth factor |
-
1985
- 1985-11-08 EP EP19900106079 patent/EP0383363A3/en not_active Withdrawn
- 1985-11-08 WO PCT/US1985/002205 patent/WO1986003122A1/en active IP Right Grant
- 1985-11-08 GB GB8617658A patent/GB2248777B/en not_active Expired - Fee Related
- 1985-11-08 EP EP85905980A patent/EP0202298B1/en not_active Expired - Lifetime
- 1985-11-08 DE DE19853590594 patent/DE3590594T1/de not_active Ceased
- 1985-11-08 CH CH3106/86A patent/CH673774A5/de not_active IP Right Cessation
- 1985-11-08 AT AT85905980T patent/ATE78167T1/de not_active IP Right Cessation
- 1985-11-08 NL NL8520384A patent/NL8520384A/nl unknown
- 1985-11-08 AU AU50949/85A patent/AU596954B2/en not_active Expired
- 1985-11-08 DE DE8585905980T patent/DE3586355T2/de not_active Expired - Lifetime
- 1985-11-08 HU HU86420A patent/HUT42329A/hu unknown
- 1985-11-11 IE IE2810/85A patent/IE57894B1/en not_active IP Right Cessation
- 1985-11-12 CA CA000495032A patent/CA1261259A/en not_active Expired
- 1985-11-19 IL IL77096A patent/IL77096A/xx not_active IP Right Cessation
-
1986
- 1986-07-23 NO NO862964A patent/NO170194C/no unknown
- 1986-07-25 SE SE8603228A patent/SE8603228L/xx not_active Application Discontinuation
- 1986-07-28 FI FI863087A patent/FI85219C/fi not_active IP Right Cessation
- 1986-07-28 DK DK357386A patent/DK165169C/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU5094985A (en) | 1986-06-18 |
NO862964L (no) | 1986-07-23 |
EP0202298A1 (en) | 1986-11-26 |
IE852810L (en) | 1986-05-29 |
AU596954B2 (en) | 1990-05-24 |
FI863087A (fi) | 1986-07-28 |
DK357386D0 (da) | 1986-07-28 |
SE8603228D0 (sv) | 1986-07-25 |
DK165169B (da) | 1992-10-19 |
DK357386A (da) | 1986-07-28 |
GB2248777B (en) | 1993-06-30 |
WO1986003122A1 (en) | 1986-06-05 |
CA1261259A (en) | 1989-09-26 |
NL8520384A (nl) | 1986-10-01 |
EP0383363A3 (en) | 1990-10-03 |
EP0383363A2 (en) | 1990-08-22 |
FI863087A0 (fi) | 1986-07-28 |
NO862964D0 (no) | 1986-07-23 |
SE8603228L (sv) | 1986-07-25 |
IE57894B1 (en) | 1993-05-05 |
EP0202298A4 (en) | 1988-07-04 |
DE3586355T2 (de) | 1993-01-14 |
ATE78167T1 (de) | 1992-08-15 |
GB2248777A (en) | 1992-04-22 |
DK165169C (da) | 1993-03-01 |
NO170194B (no) | 1992-06-15 |
GB8617658D0 (en) | 1986-08-28 |
DE3590594T1 (hu) | 1987-01-29 |
NO170194C (no) | 1992-09-23 |
IL77096A (en) | 1993-01-31 |
FI85219C (fi) | 1992-03-25 |
EP0202298B1 (en) | 1992-07-15 |
CH673774A5 (hu) | 1990-04-12 |
FI85219B (fi) | 1991-12-13 |
DE3586355D1 (de) | 1992-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT42329A (en) | Process for producing compositions for curing wounds | |
IL154797A0 (en) | Vascular endothelial cell growth factor that is unaccompanied by associated native glycosylation, pharmaceutical composition containing it and use thereof in the manufacture of a medicament for treating trauma affecting the vascular endothelium | |
ATE79763T1 (de) | Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen. | |
NL7601628A (nl) | Biologisch aanvaardbaar keramisch glas en toe- passing van het glas voor het vervaardigen van beenderprotesen, alsmede aldus verkregen protese. | |
NZ222551A (en) | A method of healing wounds and a method of regenerating bone; pharmaceutical composition of platelet-derived growth factor and insulin-like growth factor | |
ES2044856T3 (es) | Composicion de mortero para emplear heridas corneales. | |
JPS558797A (en) | Artificial bone material* which can be planted* by calcium phosphate ceramics in mother material | |
GB8630720D0 (en) | Cosmetic compositions | |
EP0190018A3 (en) | Use of transforming growth factor to promote wound healing and composition therefor | |
EP0141374A3 (en) | Capsule production using biologically active substrates | |
GR3000407T3 (en) | Surface-active compositions based on phosphoric esters, method of preparing them, and their use in the production of active materials | |
AU5283890A (en) | Fibroblast growth factor (fgf)-based stabilized compositions | |
EP0153915A3 (en) | A dressing and a method for the manufacture thereof | |
ATE136465T1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
HUT39960A (en) | Plant growth regulating composition containing 1-phenyl-imidazole-5-carboxylic acid as active ingredient and process for preparing the active ingredient | |
EP0161816A3 (en) | Urogastrone | |
HUT47031A (en) | Process and composition for increasing the development of selection tissues | |
BR9002240A (pt) | Processo para a preparacao de uma composicao conservada apropriada para aplicacao topica a pele e composicao | |
PH23594A (en) | Method of promoting wound-healing | |
ATE53494T1 (de) | Pharmazeutische zusammensetzungen zur behandlung des charcot-syndroms. | |
AU5448490A (en) | Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue | |
IT1184667B (it) | Procedimento di preparazione di 2-azetidinoni otticamente attivi,prodotti intermedi e prodotti finali ottenuti nonche' applicazione dei prodotti finali alla preparazione di derivati 3-amminici |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HU90 | Patent valid on 900628 |